Robson ME - Search Results

1

The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.

Weigelt B, Bi R, Kumar R, Blecua P, Mandelker DL, Geyer FC, Pareja F, James PA; kConFab Investigators; Couch FJ, Eccles DM, Blows F, Pharoah P, Li A, Selenica P, Lim RS, Jayakumaran G, Waddell N, Shen R, Norton L, Wen HY, Powell SN, Riaz N, Robson ME, Reis-Filho JS, Chenevix-Trench G. Weigelt B, et al. Among authors: robson me. J Natl Cancer Inst. 2018 Sep 1;110(9):1030-1034. doi: 10.1093/jnci/djy028. J Natl Cancer Inst. 2018. PMID: 29506079 Free PMC article.

2

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K. Kauff ND, et al. Among authors: robson me. N Engl J Med. 2002 May 23;346(21):1609-15. doi: 10.1056/NEJMoa020119. Epub 2002 May 20. N Engl J Med. 2002. PMID: 12023992 Free article.

3

Considerations in genetic counseling for inherited breast cancer predisposition.

Robson ME, Offit K. Robson ME, et al. Semin Radiat Oncol. 2002 Oct;12(4):362-70. doi: 10.1053/srao.2002.35255. Semin Radiat Oncol. 2002. PMID: 12382194

4

Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.

Kauff ND, Brogi E, Scheuer L, Pathak DR, Borgen PI, Hudis CA, Offit K, Robson ME. Kauff ND, et al. Among authors: robson me. Cancer. 2003 Apr 1;97(7):1601-8. doi: 10.1002/cncr.11225. Cancer. 2003. PMID: 12655515 Free article.

5

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.

Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Bégin LR, Offit K, Foulkes WD. Robson ME, et al. Breast Cancer Res. 2004;6(1):R8-R17. doi: 10.1186/bcr658. Epub 2003 Oct 24. Breast Cancer Res. 2004. PMID: 14680495 Free PMC article.

6

Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.

King TA, Gemignani ML, Li W, Giri DD, Panageas KS, Bogomolniy F, Arroyo C, Olvera N, Robson ME, Offit K, Borgen PI, Boyd J. King TA, et al. Among authors: robson me. Cancer Res. 2004 Aug 1;64(15):5051-3. doi: 10.1158/0008-5472.CAN-04-1283. Cancer Res. 2004. PMID: 15289302

7

Evaluation of germline PTEN mutations in endometrial cancer patients.

Black D, Bogomolniy F, Robson ME, Offit K, Barakat RR, Boyd J. Black D, et al. Among authors: robson me. Gynecol Oncol. 2005 Jan;96(1):21-4. doi: 10.1016/j.ygyno.2004.09.024. Gynecol Oncol. 2005. PMID: 15589575

8

Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

Kauff ND, Mitra N, Robson ME, Hurley KE, Chuai S, Goldfrank D, Wadsworth E, Lee J, Cigler T, Borgen PI, Norton L, Barakat RR, Offit K. Kauff ND, et al. Among authors: robson me. J Natl Cancer Inst. 2005 Sep 21;97(18):1382-4. doi: 10.1093/jnci/dji281. J Natl Cancer Inst. 2005. PMID: 16174860

9

Update on hereditary breast cancer.

Smith KL, Robson ME. Smith KL, et al. Among authors: robson me. Curr Oncol Rep. 2006 Jan;8(1):14-21. doi: 10.1007/s11912-006-0004-x. Curr Oncol Rep. 2006. PMID: 16464398 Review.

10

Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

King TA, Li W, Brogi E, Yee CJ, Gemignani ML, Olvera N, Levine DA, Norton L, Robson ME, Offit K, Borgen PI, Boyd J. King TA, et al. Among authors: robson me. Ann Surg Oncol. 2007 Sep;14(9):2510-8. doi: 10.1245/s10434-007-9372-1. Epub 2007 Jun 29. Ann Surg Oncol. 2007. PMID: 17597348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page